Fuji, Nichi-Iko, Sawai Aim At Generic Cancer Drugs Instead Of Lifestyle
This article was originally published in PharmAsia News
Executive Summary
Fuji Pharma, Nichi-Iko Pharmaceutical and Sawai Pharmaceutical are focusing on generics of cancer drugs as the trio attempt separately to develop new revenue sources in a shift from lifestyle drugs.